Trilineage myelodysplasia and hemophagocytosis associated with systemic lupus erythematosus

Am J Hematol. 2012 May;87(5):529-30. doi: 10.1002/ajh.22144. Epub 2011 Oct 31.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Acute Kidney Injury / etiology
  • Acute Kidney Injury / urine
  • Adult
  • Blood Component Transfusion
  • Bone Marrow / pathology
  • Cell Lineage*
  • Combined Modality Therapy
  • Darbepoetin alfa
  • Erythropoietin / analogs & derivatives
  • Erythropoietin / therapeutic use
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Hematuria / etiology
  • Humans
  • Lupus Erythematosus, Systemic / blood
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Nephritis / complications
  • Lupus Nephritis / urine
  • Lymphohistiocytosis, Hemophagocytic / blood
  • Lymphohistiocytosis, Hemophagocytic / diagnosis
  • Lymphohistiocytosis, Hemophagocytic / etiology*
  • Male
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / therapeutic use
  • Myelodysplastic Syndromes / blood
  • Myelodysplastic Syndromes / complications*
  • Myelodysplastic Syndromes / drug therapy
  • Myelodysplastic Syndromes / pathology
  • Pancytopenia / drug therapy
  • Pancytopenia / etiology
  • Pancytopenia / pathology
  • Pancytopenia / therapy
  • Pericarditis / complications
  • Prednisone / therapeutic use
  • Proteinuria / etiology
  • Recombinant Proteins / therapeutic use

Substances

  • Recombinant Proteins
  • Erythropoietin
  • Granulocyte Colony-Stimulating Factor
  • Darbepoetin alfa
  • Mycophenolic Acid
  • Filgrastim
  • Prednisone